Endeavour Silver posts Q3 silver equivalent production of 3.6 million oz
Bitget2026/10/08 10:50Endeavour Silver reported Q3 2026 production of 2,096,545 oz silver, up 19%, with 10,126 oz gold, up 39%. Silver-equivalent output rose 19% to 3,611,034 oz; sales totaled 1,900,368 oz silver, up 8%, with 9,499 oz gold, up 27%. Year-to-date silver production reached 5,915,874 oz, up 33%; gold totaled 32,340 oz, up 38%; silver-equivalent rose 40% to 10,390,771 oz. Terronera was suspended Aug. 12-24, trimming throughput to 165,171 tonnes from 175,729; it produced 710,670 oz silver, 7,157 oz gold. Full-year production and cost guidance is being recalculated; output expected at or slightly below the low end of the range. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Endeavour Silver Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080650PRIMZONEFULLFEED9841886) on October 08, 2026, and is solely responsible for the information contained therein.
- Endeavour Silver reported Q3 2026 production of 2,096,545 oz silver, up 19%, with 10,126 oz gold, up 39%.
- Silver-equivalent output rose 19% to 3,611,034 oz; sales totaled 1,900,368 oz silver, up 8%, with 9,499 oz gold, up 27%.
- Year-to-date silver production reached 5,915,874 oz, up 33%; gold totaled 32,340 oz, up 38%; silver-equivalent rose 40% to 10,390,771 oz.
- Terronera was suspended Aug. 12-24, trimming throughput to 165,171 tonnes from 175,729; it produced 710,670 oz silver, 7,157 oz gold.
- Full-year production and cost guidance is being recalculated; output expected at or slightly below the low end of the range.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
